166 related articles for article (PubMed ID: 36682980)
1. Current Status and Future Perspective on Molecular Imaging and Treatment of Neuroblastoma.
Feng L; Li S; Wang C; Yang J
Semin Nucl Med; 2023 Jul; 53(4):517-529. PubMed ID: 36682980
[TBL] [Abstract][Full Text] [Related]
2. 123I-MIBG scintigraphy and 18F-FDG-PET imaging for diagnosing neuroblastoma.
Bleeker G; Tytgat GA; Adam JA; Caron HN; Kremer LC; Hooft L; van Dalen EC
Cochrane Database Syst Rev; 2015 Sep; 2015(9):CD009263. PubMed ID: 26417712
[TBL] [Abstract][Full Text] [Related]
3. Nuclear Medicine Imaging in Neuroblastoma: Current Status and New Developments.
Samim A; Tytgat GAM; Bleeker G; Wenker STM; Chatalic KLS; Poot AJ; Tolboom N; van Noesel MM; Lam MGEH; de Keizer B
J Pers Med; 2021 Apr; 11(4):. PubMed ID: 33916640
[TBL] [Abstract][Full Text] [Related]
4. Nuclear medicine procedures and neuroblastoma in childhood. Their value in the diagnosis, staging and assessment of response to therapy.
Boubaker A; Bischof Delaloye A
Q J Nucl Med; 2003 Mar; 47(1):31-40. PubMed ID: 12714952
[TBL] [Abstract][Full Text] [Related]
5. MIBG in Neuroblastoma Diagnostic Imaging and Therapy.
Sharp SE; Trout AT; Weiss BD; Gelfand MJ
Radiographics; 2016; 36(1):258-78. PubMed ID: 26761540
[TBL] [Abstract][Full Text] [Related]
6. Pediatrics: diagnosis of neuroblastoma.
Sharp SE; Gelfand MJ; Shulkin BL
Semin Nucl Med; 2011 Sep; 41(5):345-53. PubMed ID: 21803184
[TBL] [Abstract][Full Text] [Related]
7. MIBG avidity correlates with clinical features, tumor biology, and outcomes in neuroblastoma: A report from the Children's Oncology Group.
DuBois SG; Mody R; Naranjo A; Van Ryn C; Russ D; Oldridge D; Kreissman S; Baker DL; Parisi M; Shulkin BL; Bai H; Diskin SJ; Batra V; Maris JM; Park JR; Matthay KK; Yanik G
Pediatr Blood Cancer; 2017 Nov; 64(11):. PubMed ID: 28383813
[TBL] [Abstract][Full Text] [Related]
8.
Biassoni L; Privitera L
Indian J Nucl Med; 2021; 36(3):293-299. PubMed ID: 34658554
[TBL] [Abstract][Full Text] [Related]
9. Neuroblastoma: MIBG Imaging and New Tracers.
Pfluger T; Piccardo A
Semin Nucl Med; 2017 Mar; 47(2):143-157. PubMed ID: 28237003
[TBL] [Abstract][Full Text] [Related]
10.
Aboian MS; Huang SY; Hernandez-Pampaloni M; Hawkins RA; VanBrocklin HF; Huh Y; Vo KT; Gustafson WC; Matthay KK; Seo Y
J Nucl Med; 2021 Jan; 62(1):43-47. PubMed ID: 32414950
[TBL] [Abstract][Full Text] [Related]
11. The role of 99Tcm-sestamibi scintigraphy in the staging and prediction of the therapeutic response of stage IV neuroblastoma: comparison with 131I-MIBG and 99Tcm-MDP scintigraphy.
Burak Z; Yüksel DA; Cetingül N; Kantar M; Ozkiliç H; Moretti JL
Nucl Med Commun; 1999 Nov; 20(11):991-1000. PubMed ID: 10572908
[TBL] [Abstract][Full Text] [Related]
12. MIBG in neuroblastoma diagnosis and treatment.
Olecki E; Grant CN
Semin Pediatr Surg; 2019 Dec; 28(6):150859. PubMed ID: 31931960
[TBL] [Abstract][Full Text] [Related]
13. [123I-metaiodobenzylguanidine (MIBG) scintigraphy for the staging of neuroblastoma].
Okuyama C; Ushijima Y; Sugihara H; Okitsu S; Maeda T
Kaku Igaku; 1998 Nov; 35(9):835-42. PubMed ID: 9916399
[TBL] [Abstract][Full Text] [Related]
14. The evidence-based role of catecholaminergic PET tracers in Neuroblastoma. A systematic review and a head-to-head comparison with mIBG scintigraphy.
Piccardo A; Treglia G; Fiz F; Bar-Sever Z; Bottoni G; Biassoni L; Borgwardt L; de Keizer B; Jehanno N; Lopci E; Kurch L; Massollo M; Nadel H; Roca Bielsa I; Shulkin B; Vali R; De Palma D; Cecchin D; Santos AI; Zucchetta P
Eur J Nucl Med Mol Imaging; 2024 Feb; 51(3):756-767. PubMed ID: 37962616
[TBL] [Abstract][Full Text] [Related]
15. 18F-FDG PET/CT and 123I-metaiodobenzylguanidine imaging in high-risk neuroblastoma: diagnostic comparison and survival analysis.
Papathanasiou ND; Gaze MN; Sullivan K; Aldridge M; Waddington W; Almuhaideb A; Bomanji JB
J Nucl Med; 2011 Apr; 52(4):519-25. PubMed ID: 21421719
[TBL] [Abstract][Full Text] [Related]
16. Ten years of experience with MIBG applications and the potential of new radiolabeled peptides: a personal overview and concluding remarks.
Shapiro B
Q J Nucl Med; 1995 Dec; 39(4 Suppl 1):150-5. PubMed ID: 9002776
[TBL] [Abstract][Full Text] [Related]
17. Modern nuclear medicine evaluation of neuroblastoma.
Pflüger T; Schmid I; Coppenrath E; Weiss M
Q J Nucl Med Mol Imaging; 2010 Aug; 54(4):389-400. PubMed ID: 20823807
[TBL] [Abstract][Full Text] [Related]
18. Added value of SPECT/CT for correlation of MIBG scintigraphy and diagnostic CT in neuroblastoma and pheochromocytoma.
Rozovsky K; Koplewitz BZ; Krausz Y; Revel-Vilk S; Weintraub M; Chisin R; Klein M
AJR Am J Roentgenol; 2008 Apr; 190(4):1085-90. PubMed ID: 18356459
[TBL] [Abstract][Full Text] [Related]
19. Theranostics in Neuroblastoma.
Rafael MS; Cohen-Gogo S; Irwin MS; Vali R; Shammas A; Morgenstern DA
PET Clin; 2021 Jul; 16(3):419-427. PubMed ID: 34053585
[TBL] [Abstract][Full Text] [Related]
20. PET/CT imaging in neuroblastoma.
Piccardo A; Lopci E; Conte M; Foppiani L; Garaventa A; Cabria M; Villavecchia G; Fanti S; Cistaro A
Q J Nucl Med Mol Imaging; 2013 Mar; 57(1):29-39. PubMed ID: 23474633
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
